COGNULAN Trademark
Trademark Overview
On Wednesday, January 26, 2022, a trademark application was filed for COGNULAN with the United States Patent and Trademark Office. The USPTO has given the COGNULAN trademark a serial number of 97238721. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, November 19, 2024. This trademark is owned by Eli Lilly and Company. The COGNULAN trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
General Information
| Serial Number | 97238721 |
| Word Mark | COGNULAN |
| Filing Date | Wednesday, January 26, 2022 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Tuesday, November 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 25, 2022 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 31, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
Trademark Events
| Event Date | Event Description |
| Saturday, January 29, 2022 | NEW APPLICATION ENTERED |
| Monday, January 31, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 20, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, September 20, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 5, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 25, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 25, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 20, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, May 15, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, May 15, 2023 | SOU EXTENSION 1 FILED |
| Monday, May 15, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, May 17, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, November 13, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, November 13, 2023 | SOU EXTENSION 2 FILED |
| Monday, November 13, 2023 | SOU EXTENSION 2 GRANTED |
| Wednesday, November 15, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 16, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 16, 2024 | SOU EXTENSION 3 GRANTED |
| Thursday, May 16, 2024 | SOU EXTENSION 3 FILED |
| Friday, May 17, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 19, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 19, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 19, 2024 | SOU EXTENSION 4 FILED |
| Tuesday, November 19, 2024 | SOU EXTENSION 4 GRANTED |
